Among the many antitumor effects of ICOS reported, it has been observed that higher levels improve patient prognosis in lung adenocarcinoma and are associated with the inhibition of tumor progression and a healthier tumor immune microenvironment (enriched T cell numbers and improved ImmuneScore and ESTIMATEscore) [34]. The gene discussed is ICOS; the disease is neoplasm.